首页> 美国卫生研究院文献>Digestive Diseases (Basel Switzerland) >Acetaminophen - Dose-dependent Drug Hepatotoxicity and Acute Liver Failure in Patients
【2h】

Acetaminophen - Dose-dependent Drug Hepatotoxicity and Acute Liver Failure in Patients

机译:对乙酰氨基酚-剂量依赖性药物的肝毒性和患者的急性肝衰竭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDrug-induced liver injury (DILI) is a rare but serious clinical problem. A number of drugs can cause severe liver injury and acute liver failure (ALF) at therapeutic doses in a very limited number of patients (<1:10,000). This idiosyncratic DILI (iDILI), which is currently not predictable in preclinical safety studies, appears to depend on individual susceptibility and the inability to adapt to the cellular stress caused by a particular drug. In striking contrast to iDILI, drugs with dose-dependent hepatotoxicity are mostly detected during preclinical studies and do not reach the market. One notable exception is acetaminophen (APAP, paracetamol), which is a safe drug at therapeutic doses but can cause severe liver injury and ALF after intentional and unintentional overdoses.
机译:背景药物性肝损伤(DILI)是一种罕见但严重的临床问题。在极少数患者(<1:10,000)中,许多药物可以以治疗剂量引起严重的肝损伤和急性肝衰竭(ALF)。目前在临床前安全性研究中尚无法预测的这种特异的DILI(iDILI)似乎取决于个人的敏感性和无法适应由特定药物引起的细胞应激。与iDILI形成鲜明对比的是,具有剂量依赖性肝毒性的药物大多是在临床前研究中发现的,并没有投放市场。对乙酰氨基酚(APAP,对乙酰氨基酚)是一个值得注意的例外,它是治疗剂量的安全药物,但在有意和无意过量服用后会引起严重的肝损伤和ALF。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号